Generex Biotechnology Corporation (Nasdaq:GNBT) announced today that the European Patent Office has granted the Company a new European patent, titled "Mixed Micellar Delivery System and Method of Preparation."
The patent will be validated in eleven European countries including the U.K., France and Germany. The patent contains process and formulation claims to a pharmaceutical formulation for delivery through the mucosal membranes.
"We are pleased to continue to expand our patent portfolio in Europe, which is part of the Company's European and global growth strategy," said Rose C. Perri, the Company's Chief Operating Officer.
Generex currently holds an aggregate of 123 patents worldwide (21 of which are United States Patents) and has an aggregate of 92 patent applications pending in various jurisdictions.
No comments:
Post a Comment